Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.21B | $2.28B | $2.68B | $2.42B | $2.58B | $2.70B | $2.23B | $1.97B | $1.73B | $1.49B |
| Revenue growth | — | 3.2% | 17.5% | -9.7% | 6.7% | 4.4% | -17.4% | -11.5% | -12.0% | -14.3% |
| Gross profit | $1.71B | $1.78B | $2.04B | $1.84B | $1.92B | $2.02B | $1.59B | $1.36B | $1.18B | $1.03B |
| Gross margin | 77.3% | 78.0% | 76.3% | 76.0% | 74.5% | 75.0% | 71.7% | 68.9% | 68.2% | 69.4% |
| Operating income | $231M | $274M | $241M | $267M | $258M | $234M | $111M | $48.3M | -$152M | $65.8M |
| Operating margin | 10.5% | 12.0% | 9.0% | 11.0% | 10.0% | 8.7% | 5.0% | 2.5% | -8.8% | 4.4% |
| Net income | $143M | $129M | $122M | $174M | $191M | $147M | $105M | $8.60M | -$147M | $160M |
| Net margin | 6.5% | 5.7% | 4.5% | 7.2% | 7.4% | 5.5% | 4.7% | 0.4% | -8.5% | 10.8% |
| EPS (diluted) | $2.55 | $2.36 | $2.16 | $3.10 | $3.63 | $2.86 | $2.07 | $0.17 | -$2.95 | $3.18 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $275M | $303M | $203M | $178M | $379M | $142M | $108M | $119M | $112M | $80.3M |
| Capital expenditures | $50.2M | $60.2M | $70.4M | $66.1M | $63.8M | $68.6M | $59.1M | $58.5M | $41.6M | $34.3M |
| Free cash flow | $225M | $242M | $132M | $112M | $315M | $73.0M | $49.0M | $60.1M | $70.2M | $46.0M |
| Share buybacks | $247M | $71.7M | $69.6M | $825K | $144M | $80.4M | $70.0M | $13.0M | $0.00 | $20.0M |
| Dividends paid | $78.4M | $76.1M | $80.6M | $82.2M | $78.4M | $76.3M | $77.0M | $77.6M | $11.9M | $11.8M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $357M | $426M | $387M | $336M | $403M | $340M | $265M | $256M | $187M | $239M |
| Total assets | $1.47B | $1.59B | $1.69B | $1.77B | $1.96B | $1.91B | $1.82B | $1.81B | $1.47B | $1.41B |
| Total liabilities | $810M | $885M | $913M | $894M | $1.06B | $994M | $924M | $987M | $817M | $600M |
| Long-term debt | $334M | $311M | $361M | $334M | $305M | $269M | $377M | $478M | $364M | $204M |
| Shareholders' equity | $664M | $705M | $782M | $875M | $894M | $913M | $897M | $822M | $651M | $805M |
| Retained earnings | $1.56B | $1.61B | $1.64B | $1.73B | $1.84B | $1.91B | $1.94B | $1.87B | $1.71B | $1.86B |
| Shares (wtd avg diluted) | 56.1M | 54.9M | 56.5M | 55.9M | 52.8M | 51.4M | 50.5M | 49.9M | 49.7M | 50.3M |
Every figure is extracted from NU SKIN ENTERPRISES, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.